Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prevalence of Metabolic Syndrome in Patients With Psoriasis and Psoriatic Arthritis and Its Correlation With Disease Severity and Serum Omentin-1 and Visfatin Levels

NCT03932110 is registered in ClinicalTrials.gov with Istanbul Medeniyet University as lead sponsor.

NCT NCT03932110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03932110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prevalence of Metabolic Syndrome in Patients With Psoriasis and Psoriatic Arthritis and Its Correlation With Disease Severity and Serum Omentin-1 and Visfatin Levels
Lead sponsor
Istanbul Medeniyet University
Phase
Not applicable
Overall status
Completed
Start date
April 15, 2019
Completion date
June 14, 2019
Enrollment
180 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, psoriasis vulgaris, psoriatic arthritis